Sio Gene Therapies Inc
F:6YY
Sio Gene Therapies Inc
F:6YY
Price:
0.3265
EUR
Market Cap:
€24.2m
Balance Sheet
Balance Sheet Decomposition
Sio Gene Therapies Inc
Sio Gene Therapies Inc
Balance Sheet Decomposition is not available for
Sio Gene Therapies Inc
Sio Gene Therapies Inc
Balance Sheet
Sio Gene Therapies Inc
Sio Gene Therapies Inc
Currency: USD
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
0
|
276
|
213
|
154
|
107
|
81
|
119
|
64
|
|
| Cash Equivalents |
0
|
276
|
213
|
154
|
107
|
81
|
119
|
64
|
|
| Total Receivables |
0
|
1
|
1
|
2
|
2
|
2
|
6
|
2
|
|
| Other Current Assets |
1
|
5
|
7
|
2
|
6
|
3
|
7
|
6
|
|
| Total Current Assets |
1
|
282
|
220
|
158
|
115
|
85
|
132
|
72
|
|
| PP&E Net |
0
|
0
|
0
|
3
|
1
|
2
|
2
|
3
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
6
|
6
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
3
|
0
|
1
|
0
|
1
|
0
|
|
| Total Assets |
1
N/A
|
283
+25 582%
|
223
-21%
|
161
-28%
|
123
-24%
|
94
-24%
|
135
+44%
|
75
-44%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
1
|
9
|
4
|
2
|
4
|
1
|
4
|
|
| Accrued Liabilities |
1
|
8
|
31
|
30
|
17
|
10
|
9
|
7
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
10
|
21
|
15
|
0
|
0
|
|
| Other Current Liabilities |
2
|
8
|
7
|
3
|
3
|
2
|
1
|
2
|
|
| Total Current Liabilities |
4
|
16
|
46
|
47
|
44
|
32
|
11
|
13
|
|
| Long-Term Debt |
0
|
0
|
51
|
43
|
23
|
0
|
0
|
0
|
|
| Other Liabilities |
5
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
|
| Total Liabilities |
9
N/A
|
16
+78%
|
98
+518%
|
90
-8%
|
67
-26%
|
32
-52%
|
12
-63%
|
15
+25%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
21
|
154
|
335
|
557
|
686
|
759
|
791
|
863
|
|
| Additional Paid In Capital |
13
|
421
|
460
|
628
|
741
|
820
|
914
|
923
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Equity |
8
N/A
|
267
N/A
|
125
-53%
|
71
-43%
|
56
-21%
|
62
+10%
|
123
+100%
|
60
-51%
|
|
| Total Liabilities & Equity |
1
N/A
|
283
+25 582%
|
223
-21%
|
161
-28%
|
123
-24%
|
94
-24%
|
135
+44%
|
75
-44%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
12
|
12
|
12
|
14
|
23
|
40
|
69
|
74
|
|
Switch to:
Switch to:
See Also
Discover More
